VF
TXMD icon

Virtu Financial’s TherapeuticsMD TXMD Stock Holding History

Virtu Financial’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,762
Closed -$105K – 1976
2021
Q2 		$105K Sell
1,762
-6,863
-80% -$416K 0.01% 1193
2021
Q1 		$578K Sell
8,625
-2,738
-24% -$214K 0.04% 453
2020
Q4 		$687K Buy
+11,363
New +$776K 0.07% 344
2020
Q3 		– Sell
-1,166
Closed -$73K – 1529
2020
Q2 		$73K Buy
+1,166
New +$67.9K 0.01% 946
2019
Q4 		$397K Buy
+3,278
New +$471K 0.04% 526
2019
Q3 		– Sell
-2,550
Closed -$332K – 1861
2019
Q2 		$332K Buy
2,550
+1,529
+150% +$274K 0.02% 731
2019
Q1 		$249K Buy
+1,021
New +$270K 0.01% 883
2017
Q4 		– Sell
-1,381
Closed -$365K – 3024
2017
Q3 		$365K Buy
+1,381
New +$399K 0.02% 1191

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's TXMD Position: Q3 2021 in Review

Virtu Financial sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 1,762 shares — an estimated $105K sold.

Virtu Financial first reported a position in TXMD in Q3 2017 and held it in 8 quarters. The position peaked at $687K in Q4 2020. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • Virtu Financial reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • Virtu Financial sold 1,762 TherapeuticsMD shares in Q3 2021, an estimated $105K.
  • Virtu Financial first reported a position in TherapeuticsMD in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's TherapeuticsMD position peaked at $687K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Virtu Financial's 13F filing for Q3 2021, filed 12 Nov 2021.